CLINICAL_TRIALS
trial_result
· 2018-12-10
Clinical Trial Update: Study of Denosumab in Subjects With Giant Cell Tumor of Bone [Phase 2]
Summary
Phase 2 trial of denosumab in giant cell tumor of bone has completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Cancer, Giant Cell Tumors | Phase 2 | Status: COMPLETED | Results posted: 2018-12-10